Finance

Lists
002020:SHE
Zhejiang Jingxin Pharmaceutical Co., Ltd
11,38 CN¥
-1,30%
(-0,15) 1D
15 қаз., 15:04:42 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002020...
Open
11,41 CN¥
High
11,63 CN¥
Low
11,30 CN¥
Mkt. cap
9,89 млрд
Avg. vol.
12,72 млн
Volume
12,43 млн
Dividend
3,08%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 11 мау.
P/E ratio
12,74
52-wk high
21,65 CN¥
52-wk low
11,11 CN¥
EPS
0,89 CN¥
Shares outstanding
861,03 млн
No. of employees
4 мың
Open
11,41 CN¥
High
11,63 CN¥
Low
11,30 CN¥
Mkt. cap
9,89 млрд
Avg. vol.
12,72 млн
Volume
12,43 млн
Dividend
3,08%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 11 мау.
P/E ratio
12,74
52-wk high
21,65 CN¥
52-wk low
11,11 CN¥
EPS
0,89 CN¥
Shares outstanding
861,03 млн
No. of employees
4 мың
News stories
From web sources and news partners
About Zhejiang Jingxin Pharmaceutical Co., Ltd
CEO-
Employees3,73 мың
Founded1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,03 млрд
1,02 млрд
923,03 млн
1,06 млрд
Cost of goods sold
506,52 млн
540,75 млн
451,52 млн
554,56 млн
Cost of revenue
506,52 млн
540,75 млн
451,52 млн
554,56 млн
Research and development expenses
89,68 млн
93,56 млн
83,03 млн
81,74 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220,72 млн
200,08 млн
186,30 млн
185,69 млн
Operating expense
333,83 млн
292,95 млн
280,97 млн
282,38 млн
Total operating expenses
840,35 млн
833,70 млн
732,49 млн
836,94 млн
Operating income
191,30 млн
187,47 млн
190,55 млн
227,21 млн
Other non operating income
-969,56 м.
1,49 млн
-14,07 млн
13,33 млн
EBT including unusual items
214,65 млн
199,41 млн
191,37 млн
221,16 млн
EBT excluding unusual items
206,53 млн
197,34 млн
189,61 млн
241,52 млн
Income tax expense
25,44 млн
14,16 млн
25,22 млн
31,36 млн
Effective tax rate
11,85%
7,10%
13,18%
14,18%
Other operating expenses
17,32 млн
5,19 млн
13,98 млн
14,51 млн
Net income
187,73 млн
182,37 млн
165,20 млн
186,42 млн
Net profit margin
18,20%
17,86%
17,90%
17,52%
Earnings per share
-
-
-
-
Interest and investment income
19,21 млн
18,40 млн
14,30 млн
24,19 млн
Interest expense
-1,63 млн
-
-1,17 млн
-390,99 м.
Net interest expenses
17,58 млн
18,40 млн
13,14 млн
23,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
260,03 млн
254,25 млн
257,33 млн
293,99 млн
Gain or loss from assets sale
-256,69 м.
574,50 м.
-
-6,12 млн
AI content may include mistakes. Learn more
Google қолданбалары